Yarlagadda S. Babu, VP Drug Discovery at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 200 shares at $10.00 ($2K) on 2009-10-21, disclosed to the SEC on 2009-10-22.
Scheduled sale ($2k) by VP Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCRX | SELL | 2021-12-09 | $367K | — | Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |